European Journal of Haematology

Papers
(The H4-Index of European Journal of Haematology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
85
50
Clinical efficacy of simoctocog alfa versus extended half‐life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching‐adjusted indirect48
Comparison of Hetrombopag and Eltrombopag Added to First‐Line Immunosuppressive Therapy in Severe Aplastic Anemia42
Efficacy and Safety of Bendamustine‐Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma42
Enhancing thalassemia gene carrier identification in non‐anemic populations using artificial intelligence erythrocyte morphology analysis and machine learning37
Issue Information30
Issue Information29
The association of age and adverse events of PEG‐asparaginase in a pediatric tertiary care hospital; a retrospective review27
Long‐term effectiveness of eculizumab: Data from the International PNH Registry27
Plasma microbial cell‐free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia26
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma23
Flow cytometry for comprehensive assessment of platelet functional activity in response to ADP stimulation23
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes23
Pixantrone as a bridge to CAR‐T treatment in high‐grade transformation of follicular lymphoma22
Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)‐T cell therapy in patients with hematological malignancy22
Individualized busulfan dosing improves outcomes compared to fixed‐dose administration in pre‐transplant minimal residual disease‐positive acute myeloid leukemia patients with intermediate‐risk underg20
Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea19
Vaccination in Multiple Myeloma: Challenges and Strategies19
1.4876050949097